Joyhas carved a niche for herself as an actress who masterfully embodies characters grappling with the darker sides of ...

ONCE known for her wild antics on Celebrity Big Brother and Ex On The Beach, Jemma Lucy has since traded in late-night ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Some of the best and strongest prequels succeed because they break free from the constraints of traditional origin stories.

Maya Mehrara is a News Reporter at Newsweek based in London, U.K.. Her focus is reporting on international news. She has covered Ukraine, Russia, immigration issues, and the revolution in Iran ...

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

Before joining Raw Story, Brad Reed spent eight years writing about technology at BGR.com and Network World. Prior to that, he wrote freelance stories for political publications such as AlterNet ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

CM Punk shared an update on his health after his wild brawl with Seth Rollins this past Monday night on WWE RAW. The Visionary hit Punk with a Stomp after being eliminated in the Men's Elimination ...

Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is making larger doses available for $499 through its self-pay program.